The Lattice (Official 3DHEALS Podcast)

We put a price tag on “saving a life” by comparing blockbuster AI spending with the tiny budgets aimed at artificial organs and organ regeneration. We walk through why bioprinted kidneys are so hard to build, why kidney failure is such a massive economic burden, and what smarter near-term bets could look like.  This podcast is just a summary.  Read the full article here:  https://3dheals.com/how-m...

Ossiform is on track to bring the first 3D printed resorbable bone implant to the US market. The company’s preclinical data showed full bone regeneration in six months. Monica Wellejus, Chief Commercial Officer of Ossiform, joins The Lattice to explain how a company built to personalize bone implants for craniomaxillofacial surgeries is pivoting to mass-produced bone implants for foot deformity, a...

What does it take to invent a technology that didn't exist before? In this episode, host Dr. Jenny Chen sits down with Professor Paul Dalton, the inventor of melt electrowriting (MEW) and one of the rare "triple threats" in science: an inventor, educator, and futurist. This is also a conversation about science, creativity, and why MEW isn't just a technology but a movement. Pau...

Surgery is moving into a world where we can measure, simulate, and even rehearse before we ever touch a patient, but getting 3D surgical planning to feel “normal” inside a hospital is still a battle. We bring together a rare mix of voices across the ecosystem to explain what’s actually working, what’s still missing, and what it takes to scale medical 3D printing and virtual surgical planning witho...

This is our second episode recorded at the Materialise conference.  Our guest for this episode is no other than the CEO of Materialise Brigitte de Vet-Veithen. It is a pleasure for me to be able to conduct this interview, because Materialise is such a legendary company that has spent 35 years building the software and services infrastructure behind patient-specific implants, surgical planning, and...

This is one of two episodes we have recorded during our trip to Leuven Belgium for the Materialise 2026 Conference, focusing on 3D planning and 3D printing in hospitals. We talked with Dr. Tristan Remcharan about how pediatric cardiology imaging can become something you can literally hold, using 3D segmentation and 3D printing to make congenital heart disease easier to plan, teach, and explain. We...

You can learn a lot about the future of healthcare by watching how a single pill gets made. From a small office in London, we sit down with Prof Alvaro Goyanes, co-founder and CEO of FabRx , to unpack how 3D printed pharmaceuticals are turning personalized medicine from an idea into a working system. If you’ve ever wondered why patients still get forced into a handful of standard doses, this conve...

Everyone talks about printing organs, but the closest thing to real impact often starts with something less flashy and far more practical: the materials. We bring together founders and operators working across bioprinted implants, structural bone substitutes, cryopreserved tissue models, and natural biopolymer manufacturing to answer one question that matters: what actually makes advanced biofabri...

Neurotech is the category most investors whisper about and then walk away from: too technical, too regulated, too slow. We wanted to talk to someone who leans in anyway, so I sat down with Varun Turlapati, founder of Chanakya Capital, to hear how he’s building an early-stage fund dedicated to neurotech devices and why he thinks the “long horizon” objection often misses what’s actually happening on...

We track the biggest healthcare 3D printing stories from March 2026, from bioprinted organs and sustainable bioinks to FDA-cleared implants and hospital point-of-care wins. We also look at how 3D printed cancer tools, training models, microrobots, and AI quality control are moving from research into real clinical and manufacturing workflows.  • bioprinted uterus model for preterm labor drug testin...

What happens when a hospital needs a simple part but the supply chain takes weeks or months to deliver it? Dr. Stephan Ryan , physician and co-founder of PolyUnity , set out to solve that problem by helping hospitals produce parts themselves through safe, compliant 3D printing. In this episode, Stephen Ryan shares how early clinical experiences and an academic 3D printing lab evolved into a platfo...

We map the biggest shifts in healthcare 3D printing this month, from emissions safety to custom eyewear, implant surfaces, microfluidics, and space-based biomanufacturing. We weigh promise against risk and share where standards and design can close the gap. • emissions from desktop and industrial printers and why they matter  • safeguards for vulnerable groups and safer materials and testing  • fa...

We share how a decade of soft robotics, open APIs, and relentless iteration turned a 3D-printed prototype into a durable, touch-sensing bionic hand used by amputees and robots. Stories of failure, funding, and firsts reveal how speed, sensation, and design choices translate to real lives and real factories. • early 3D printing wins and durability limits • shift to soft robotics, silicone overmoldi...

We track a month of fast-moving news in healthcare 3D printing, from organ-scale bioprinting programs and ARPA-H’s funding model to point-of-care tools already entering clinics. The throughline is clear: vascularization, immune compatibility, and scale are converging with real-world deployment. • UT Southwestern’s organoid-plus-bioprinting strategy for durable liver tissue • Carnegie Mellon’s cons...

A crowded JP Morgan week can blur into noise, so we built a quieter stage to focus on what actually moves healthcare forward: 3D software‑planned care, on‑demand manufacturing, and proof that patients and payers can feel. Recorded live in San Francisco, this special episode brings founders and investors together to show how 3D data and advanced manufacturing are turning personalization into a scal...

We explore how to move IVIG from donor scarcity to on‑demand manufacturing with tissue‑engineered bioreactors, and why that shift could lower costs, expand access, and improve consistency. We dig into polyclonal advantages, regulatory guardrails, scaling plans, and what success would mean for complex biologics beyond antibodies. • Defining a bioreactor that recreates human tissue niches • Why poly...

In this episode, Alyssa Huffman, CEO and co-founder of Allumin8, shares the six-year journey behind a first-of-its-kind 5.5 mm porous, 3D-printed pedicle screw. We discussed how Allumin8 earned FDA clearance and why design details matter for fatigue, fixation, and fewer revisions. We also map a path toward therapeutic hardware that integrates orthobiologics without slowing surgeons down. Critical...

Imagine holding a child’s heart in your hands and seeing the exact path a surgeon must take before a single incision. That shift from uncertainty to clarity frames this conversation on how 3D printing, virtual reality, and advanced imaging are transforming pediatric cardiology. Our speakers show how AI-assisted segmentation, multimodality fusion, VR rehearsal, and rapid mixed-reality planning are...

In this episode, Dr. Karolina Valente, Founder and CEO of VoxCell BioInnovation, discusses her journey in biotechnology, focusing on 3D bioprinting and its impact on cancer research and drug discovery. She shares insights into her leadership at VoxCell, the company's growth, and the accolades it has received. Dr. Valente also talks about the importance of partnerships, the future of biotechno...

Summary In this conversation, Jenny Chen explores the complex implications of ChatGPT on intelligence and education. She emphasizes the need for careful consideration of the technology's impact, particularly in academic settings, and discusses the broader context of a technological revolution that may have both positive and negative consequences. Takeaways Is ChatGPT making us dumb? This is a...

How well do we really understand the body? For decades, surgeons have relied on static scans and flat 2D models to plan procedures. Gilly Yildirim believes it’s time to expand our view to more dimensions. As founder and CEO of Vent Creativity , he is bringing together point clouds, digital twins, and physics-based AI to capture movement with a level of precision that static imaging is far from. In...

Microfluidics has long promised to reshape diagnostics, drug discovery, and laboratory science. Microfluidics is about manipulating how tiny amounts of liquid move through channels no wider than a human hair; a "lab on a chip" diagnostic. Now imagine being able to 3D print those channels instead of painstakingly etching them. Paul Marshall , CEO of Rapid Fluidics , is working to improve...

What happens when advanced mathematics meets manufacturing? The result is a new way of creating products that range from record-breaking running shoes to life-changing medical devices. In this episode, we sit down with Elissa Ross , mathematician and CEO of Metafold 3D , to explore how her company is using mathematics to reshape design and manufacturing. Metafold’s platform is built on geometric i...

Cartilage injuries sideline millions every year, yet current treatments often fail to restore long-term function. In this episode, Dr. Nathan Castro and Dr. Ben Holmes, co-founders of Nanochon , explain how they are tackling this challenge with a 3D-printed implant designed not only to replace damaged tissue but to help it regrow. What began as a collaboration in a graduate lab has grown into a co...

What if your medication could be made just for you? No more pill overload and no more awkward dosing workarounds. Just the exact treatment you need when you need it. That is the promise of 3D printed pharmaceuticals. Drug manufacturing has relied on a one-size-fits-all model for decades. Nearly half of all medications lack proper formulations for children and seniors are often left struggling to m...